SULFs in human neoplasia: implication as progression and prognosis factors
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SULFs in human neoplasia: implication as progression and prognosis factors
Authors
Keywords
-
Journal
Journal of Translational Medicine
Volume 9, Issue 1, Pages 72
Publisher
Springer Nature
Online
2011-05-22
DOI
10.1186/1479-5876-9-72
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Wnt signalling and the control of cellular metabolism
- (2010) Jaswinder K. Sethi et al. BIOCHEMICAL JOURNAL
- Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate
- (2010) Steven D Rosen et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma
- (2010) D. Hose et al. HAEMATOLOGICA
- Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia
- (2010) Etienne Moussay et al. Molecular Cancer
- The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor
- (2009) Anne Catherine Sprynski et al. BLOOD
- Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cells
- (2009) Caroline Bret et al. BRITISH JOURNAL OF HAEMATOLOGY
- Regulation of HSulf-1 Expression by Variant Hepatic Nuclear Factor 1 in Ovarian Cancer
- (2009) P. Liu et al. CANCER RESEARCH
- Identification of SULF2 as a Novel Transcriptional Target of p53 by Use of Integrated Genomic Analyses
- (2009) B. Nelson Chau et al. CANCER RESEARCH
- A novel SULF1 splice variant inhibits Wnt signalling but enhances angiogenesis by opposing SULF1 activity
- (2009) Amrit Paul Sahota et al. EXPERIMENTAL CELL RESEARCH
- Additive effect of apicidin and doxorubicin in sulfatase 1 expressing hepatocellular carcinoma in vitro and in vivo
- (2009) Jin-Ping Lai et al. JOURNAL OF HEPATOLOGY
- Sulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesis
- (2009) H Lemjabbar-Alaoui et al. ONCOGENE
- The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis
- (2008) Adam I Riker et al. BMC Medical Genomics
- Heparanase: One Molecule with Multiple Functions in Cancer Progression
- (2008) Israel Vlodavsky et al. CONNECTIVE TISSUE RESEARCH
- Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets
- (2008) Jin-Ping Lai et al. Future Oncology
- Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma
- (2008) Jin-Ping Lai et al. HEPATOLOGY
- Promoter hypermethylation correlates with theHsulf-1silencing in human breast and gastric cancer
- (2008) Zhao Chen et al. INTERNATIONAL JOURNAL OF CANCER
- Sulf Loss InfluencesN-, 2-O-, and 6-O-Sulfation of Multiple Heparan Sulfate Proteoglycans and Modulates Fibroblast Growth Factor Signaling
- (2008) William C. Lamanna et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Differential involvement of the extracellular 6-O-endosulfatases Sulf1 and Sulf2 in brain development and neuronal and behavioural plasticity
- (2008) Ina Kalus et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Prediction of Survival in Multiple Myeloma Based on Gene Expression Profiles Reveals Cell Cycle and Chromosomal Instability Signatures in High-Risk Patients and Hyperdiploid Signatures in Low-Risk Patients: A Study of the Intergroupe Francophone du Myélome
- (2008) Olivier Decaux et al. JOURNAL OF CLINICAL ONCOLOGY
- mRNA expression analysis and classification of colonic biopsy samples using oligonucleotide and cDNA microarray techniques
- (2008) Orsolya Galamb ORVOSI HETILAP
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started